Cargando…
Progress in L2-Based Prophylactic Vaccine Development for Protection against Diverse Human Papillomavirus Genotypes and Associated Diseases
The human papillomaviruses (HPVs) are a family of small DNA tumor viruses including over 200 genotypes classified by phylogeny into several genera. Different genera of HPVs cause ano-genital and oropharyngeal cancers, skin cancers, as well as benign diseases including skin and genital warts. License...
Autores principales: | Olczak, Pola, Roden, Richard B.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712070/ https://www.ncbi.nlm.nih.gov/pubmed/33019516 http://dx.doi.org/10.3390/vaccines8040568 |
Ejemplares similares
-
Incorporation of RG1 epitope concatemers into a self-adjuvanting Flagellin-L2 vaccine broaden durable protection against cutaneous challenge with diverse human papillomavirus genotypes
por: Kalnin, Kirill, et al.
Publicado: (2017) -
Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach
por: Wu, Wai-Hong, et al.
Publicado: (2015) -
Progress in Vaccination of Prophylactic Human Papillomavirus Vaccine
por: Zhou, Xu, et al.
Publicado: (2020) -
Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
por: Jagu, Subhashini, et al.
Publicado: (2009) -
Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
por: Schellenbacher, Christina, et al.
Publicado: (2013)